Experiments were therefore designed to test whether cd45- [cd34+/kdr+]EPCs quantitatively and/or qualitatively decline with age, and test the converse whether juvenile EPCs contribute to “on-the-ready” real-time surveillance and endothelial repair critical for the maintenance of endothelial integrity, thus capable of delaying stroke onset. Here, CD34 is linked to stroke disorder.